APO Research

APO RESEARCH · REPORT

Anxiety Relief Supplements

Selected research

Market Structure

Global Anxiety Relief Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Anxiety Relief Supplements market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Anxiety Relief Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anxiety Relief Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anxiety Relief Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Anxiety Relief Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anxiety Relief Supplements include LONZA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Nestle S.A., Merck, The Nature's Bounty Co., Now Food, Nature's Sunshine and Herbalife, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anxiety Relief Supplements market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anxiety Relief Supplements and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anxiety Relief Supplements sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anxiety Relief Supplements market size, projected growth trends, production technologies, key applications, and end-use industries.

Anxiety Relief Supplements Segment by Company

LONZA

Takeda Pharmaceutical Co. Ltd.

Teva Pharmaceutical Industries Ltd.

Nestle S.A.

Merck

The Nature's Bounty Co.

Now Food

Nature's Sunshine

Herbalife

GNC

DuPont

DSM

Ayanda

Arkopharma

Amway Corporation

Abbott Laboratories

Anxiety Relief Supplements Segment by Type

Vitamin Supplements

Magnesium Supplements

L-Theanine Supplements

Other

Anxiety Relief Supplements Segment by Application

Clinic

Pharmacy

E-commerce Platform

Supermarket

Other

Anxiety Relief Supplements Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anxiety Relief Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anxiety Relief Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anxiety Relief Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anxiety Relief Supplements market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anxiety Relief Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Anxiety Relief Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Anxiety Relief Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Anxiety Relief Supplements Industry Trends Table 2. Anxiety Relief Supplements Industry Drivers Table 3. Anxiety Relief Supplements Industry Opportunities and Challenges Table 4. Anxiety Relief Supplements Industry Restraints Table 5. Global Anxiety Relief Supplements Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Anxiety Relief Supplements Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Anxiety Relief Supplements Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Anxiety Relief Supplements Sales Market Share by Manufacturers Table 9. Global Anxiety Relief Supplements Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Anxiety Relief Supplements Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Anxiety Relief Supplements Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Anxiety Relief Supplements Manufacturers, Product Type & Application Table 13. Global Anxiety Relief Supplements Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Anxiety Relief Supplements by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Vitamin Supplements Table 17. Major Manufacturers of Magnesium Supplements Table 18. Major Manufacturers of L-Theanine Supplements Table 19. Major Manufacturers of Other Table 20. Global Anxiety Relief Supplements Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Anxiety Relief Supplements Sales by Type (2021-2026) & (k units) Table 22. Global Anxiety Relief Supplements Sales by Type (2027-2032) & (k units) Table 23. Global Anxiety Relief Supplements Sales Market Share by Type (2021-2026) Table 24. Global Anxiety Relief Supplements Sales Market Share by Type (2027-2032) Table 25. Global Anxiety Relief Supplements Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Anxiety Relief Supplements Revenue by Type (2021-2026) & (k units) Table 27. Global Anxiety Relief Supplements Revenue by Type (2027-2032) & (k units) Table 28. Global Anxiety Relief Supplements Revenue Market Share by Type (2021-2026) Table 29. Global Anxiety Relief Supplements Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Pharmacy Table 32. Major Manufacturers of E-commerce Platform Table 33. Major Manufacturers of Supermarket Table 34. Major Manufacturers of Other Table 35. Global Anxiety Relief Supplements Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Anxiety Relief Supplements Sales by Application (2021-2026) & (k units) Table 37. Global Anxiety Relief Supplements Sales by Application (2027-2032) & (k units) Table 38. Global Anxiety Relief Supplements Sales Market Share by Application (2021-2026) Table 39. Global Anxiety Relief Supplements Sales Market Share by Application (2027-2032) Table 40. Global Anxiety Relief Supplements Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Anxiety Relief Supplements Revenue by Application (2021-2026) & (k units) Table 42. Global Anxiety Relief Supplements Revenue by Application (2027-2032) & (k units) Table 43. Global Anxiety Relief Supplements Revenue Market Share by Application (2021-2026) Table 44. Global Anxiety Relief Supplements Revenue Market Share by Application (2027-2032) Table 45. Global Anxiety Relief Supplements Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Anxiety Relief Supplements Sales by Region (2021-2026) & (k units) Table 47. Global Anxiety Relief Supplements Sales Market Share by Region (2021-2026) Table 48. Global Anxiety Relief Supplements Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Anxiety Relief Supplements Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Anxiety Relief Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Anxiety Relief Supplements Sales by Country (2021-2026) & (k units) Table 52. North America Anxiety Relief Supplements Sales by Country (2027-2032) & (k units) Table 53. Europe Anxiety Relief Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Anxiety Relief Supplements Sales by Country (2021-2026) & (k units) Table 55. Europe Anxiety Relief Supplements Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Anxiety Relief Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Anxiety Relief Supplements Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Anxiety Relief Supplements Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Anxiety Relief Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Anxiety Relief Supplements Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Anxiety Relief Supplements Sales by Country (2027-2032) & (k units) Table 62. Global Anxiety Relief Supplements Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Anxiety Relief Supplements Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Anxiety Relief Supplements Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Anxiety Relief Supplements Revenue Market Share by Region (2021-2026) Table 66. Global Anxiety Relief Supplements Revenue Market Share by Region (2027-2032) Table 67. LONZA Company Information Table 68. LONZA Business Overview Table 69. LONZA Anxiety Relief Supplements Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. LONZA Anxiety Relief Supplements Product Portfolio Table 71. LONZA Recent Development Table 72. Takeda Pharmaceutical Co. Ltd. Company Information Table 73. Takeda Pharmaceutical Co. Ltd. Business Overview Table 74. Takeda Pharmaceutical Co. Ltd. Anxiety Relief Supplements Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Takeda Pharmaceutical Co. Ltd. Anxiety Relief Supplements Product Portfolio Table 76. Takeda Pharmaceutical Co. Ltd. Recent Development Table 77. Teva Pharmaceutical Industries Ltd. Company Information Table 78. Teva Pharmaceutical Industries Ltd. Business Overview Table 79. Teva Pharmaceutical Industries Ltd. Anxiety Relief Supplements Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Teva Pharmaceutical Industries Ltd. Anxiety Relief Supplements Product Portfolio Table 81. Teva Pharmaceutical Industries Ltd. Recent Development Table 82. Nestle S.A. Company Information Table 83. Nestle S.A. Business Overview Table 84. Nestle S.A. Anxiety Relief Supplements Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Nestle S.A. Anxiety Relief Supplements Product Portfolio Table 86. Nestle S.A. Recent Development Table 87. Merck Company Information Table 88. Merck Business Overview Table 89. Merck Anxiety Relief Supplements Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Merck Anxiety Relief Supplements Product Portfolio Table 91. Merck Recent Development Table 92. The Nature's Bounty Co. Company Information Table 93. The Nature's Bounty Co. Business Overview Table 94. The Nature's Bounty Co. Anxiety Relief Supplements Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. The Nature's Bounty Co. Anxiety Relief Supplements Product Portfolio Table 96. The Nature's Bounty Co. Recent Development Table 97. Now Food Company Information Table 98. Now Food Business Overview Table 99. Now Food Anxiety Relief Supplements Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Now Food Anxiety Relief Supplements Product Portfolio Table 101. Now Food Recent Development Table 102. Nature's Sunshine Company Information Table 103. Nature's Sunshine Business Overview Table 104. Nature's Sunshine Anxiety Relief Supplements Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Nature's Sunshine Anxiety Relief Supplements Product Portfolio Table 106. Nature's Sunshine Recent Development Table 107. Herbalife Company Information Table 108. Herbalife Business Overview Table 109. Herbalife Anxiety Relief Supplements Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Herbalife Anxiety Relief Supplements Product Portfolio Table 111. Herbalife Recent Development Table 112. GNC Company Information Table 113. GNC Business Overview Table 114. GNC Anxiety Relief Supplements Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. GNC Anxiety Relief Supplements Product Portfolio Table 116. GNC Recent Development Table 117. DuPont Company Information Table 118. DuPont Business Overview Table 119. DuPont Anxiety Relief Supplements Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. DuPont Anxiety Relief Supplements Product Portfolio Table 121. DuPont Recent Development Table 122. DSM Company Information Table 123. DSM Business Overview Table 124. DSM Anxiety Relief Supplements Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. DSM Anxiety Relief Supplements Product Portfolio Table 126. DSM Recent Development Table 127. Ayanda Company Information Table 128. Ayanda Business Overview Table 129. Ayanda Anxiety Relief Supplements Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Ayanda Anxiety Relief Supplements Product Portfolio Table 131. Ayanda Recent Development Table 132. Arkopharma Company Information Table 133. Arkopharma Business Overview Table 134. Arkopharma Anxiety Relief Supplements Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Arkopharma Anxiety Relief Supplements Product Portfolio Table 136. Arkopharma Recent Development Table 137. Amway Corporation Company Information Table 138. Amway Corporation Business Overview Table 139. Amway Corporation Anxiety Relief Supplements Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Amway Corporation Anxiety Relief Supplements Product Portfolio Table 141. Amway Corporation Recent Development Table 142. Abbott Laboratories Company Information Table 143. Abbott Laboratories Business Overview Table 144. Abbott Laboratories Anxiety Relief Supplements Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Abbott Laboratories Anxiety Relief Supplements Product Portfolio Table 146. Abbott Laboratories Recent Development Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Anxiety Relief Supplements Distributors List Table 150. Anxiety Relief Supplements Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Anxiety Relief Supplements Product Image Figure 2. Global Anxiety Relief Supplements Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anxiety Relief Supplements Market Size (2021-2032) & (US$ Million) Figure 4. Global Anxiety Relief Supplements Sales (2021-2032) & (k units) Figure 5. Global Anxiety Relief Supplements Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Anxiety Relief Supplements Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Vitamin Supplements Image Figure 9. Magnesium Supplements Image Figure 10. L-Theanine Supplements Image Figure 11. Other Image Figure 12. Global Anxiety Relief Supplements Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Anxiety Relief Supplements Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Anxiety Relief Supplements Sales Market Share by Type (2021-2032) Figure 15. Global Anxiety Relief Supplements Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Anxiety Relief Supplements Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Anxiety Relief Supplements Revenue Market Share by Type (2021-2032) Figure 18. Clinic Image Figure 19. Pharmacy Image Figure 20. E-commerce Platform Image Figure 21. Supermarket Image Figure 22. Other Image Figure 23. Global Anxiety Relief Supplements Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Anxiety Relief Supplements Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Anxiety Relief Supplements Sales Market Share by Application (2021-2032) Figure 26. Global Anxiety Relief Supplements Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Anxiety Relief Supplements Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Anxiety Relief Supplements Revenue Market Share by Application (2021-2032) Figure 29. North America Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Anxiety Relief Supplements Sales Market Share by Country (2021-2032) Figure 31. U.S. Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Anxiety Relief Supplements Sales Market Share by Country (2021-2032) Figure 36. Germany Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Anxiety Relief Supplements Sales Market Share by Country (2021-2032) Figure 43. China Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Anxiety Relief Supplements Sales Market Share by Country (2021-2032) Figure 51. Brazil Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Anxiety Relief Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Anxiety Relief Supplements Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Anxiety Relief Supplements Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Anxiety Relief Supplements Revenue (2021-2032) & (US$ Million) Figure 62. North America Anxiety Relief Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Anxiety Relief Supplements Revenue (2021-2032) & (US$ Million) Figure 64. Europe Anxiety Relief Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Anxiety Relief Supplements Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Anxiety Relief Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Anxiety Relief Supplements Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Anxiety Relief Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Anxiety Relief Supplements Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Anxiety Relief Supplements Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Vitamin Supplements
  • Magnesium Supplements
  • L-Theanine Supplements
  • Other
Applications
  • Clinic
  • Pharmacy
  • E-commerce Platform
  • Supermarket
  • Other
Companies covered
  • LONZA
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Nestle S.A.
  • Merck
  • The Nature's Bounty Co.
  • Now Food
  • Nature's Sunshine
  • Herbalife
  • GNC
  • DuPont
  • DSM
  • Ayanda
  • Arkopharma
  • Amway Corporation
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anxiety Relief Supplements Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anxiety Relief Supplements Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Anxiety Relief Supplements Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Anxiety Relief Supplements Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Anxiety Relief Supplements Market Dynamics
  1. 2.1 Anxiety Relief Supplements Industry Trends
  2. 2.2 Anxiety Relief Supplements Industry Drivers
  3. 2.3 Anxiety Relief Supplements Industry Opportunities and Challenges
  4. 2.4 Anxiety Relief Supplements Industry Restraints
3 Anxiety Relief Supplements Market by Manufacturers
  1. 3.1 Global Anxiety Relief Supplements Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Anxiety Relief Supplements Sales by Manufacturers (2021-2026)
  3. 3.3 Global Anxiety Relief Supplements Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Anxiety Relief Supplements Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anxiety Relief Supplements Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Anxiety Relief Supplements Manufacturers, Product Type & Application
  7. 3.7 Global Anxiety Relief Supplements Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anxiety Relief Supplements Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anxiety Relief Supplements Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anxiety Relief Supplements Tier 1, Tier 2, and Tier 3
4 Anxiety Relief Supplements Market by Type
  1. 4.1 Anxiety Relief Supplements Type Introduction
  2. 4.1.1 Vitamin Supplements
  3. 4.1.2 Magnesium Supplements
  4. 4.1.3 L-Theanine Supplements
  5. 4.1.4 Other
  6. 4.2 Global Anxiety Relief Supplements Sales by Type
  7. 4.2.1 Global Anxiety Relief Supplements Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Anxiety Relief Supplements Sales by Type (2021-2032)
  9. 4.2.3 Global Anxiety Relief Supplements Sales Market Share by Type (2021-2032)
  10. 4.3 Global Anxiety Relief Supplements Revenue by Type
  11. 4.3.1 Global Anxiety Relief Supplements Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Anxiety Relief Supplements Revenue by Type (2021-2032)
  13. 4.3.3 Global Anxiety Relief Supplements Revenue Market Share by Type (2021-2032)
5 Anxiety Relief Supplements Market by Application
  1. 5.1 Anxiety Relief Supplements Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 E-commerce Platform
  5. 5.1.4 Supermarket
  6. 5.1.5 Other
  7. 5.2 Global Anxiety Relief Supplements Sales by Application
  8. 5.2.1 Global Anxiety Relief Supplements Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Anxiety Relief Supplements Sales by Application (2021-2032)
  10. 5.2.3 Global Anxiety Relief Supplements Sales Market Share by Application (2021-2032)
  11. 5.3 Global Anxiety Relief Supplements Revenue by Application
  12. 5.3.1 Global Anxiety Relief Supplements Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Anxiety Relief Supplements Revenue by Application (2021-2032)
  14. 5.3.3 Global Anxiety Relief Supplements Revenue Market Share by Application (2021-2032)
6 Global Anxiety Relief Supplements Sales by Region
  1. 6.1 Global Anxiety Relief Supplements Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anxiety Relief Supplements Sales by Region (2021-2032)
  3. 6.2.1 Global Anxiety Relief Supplements Sales by Region (2021-2026)
  4. 6.2.2 Global Anxiety Relief Supplements Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anxiety Relief Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Anxiety Relief Supplements Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Anxiety Relief Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Anxiety Relief Supplements Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Anxiety Relief Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Anxiety Relief Supplements Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Anxiety Relief Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Anxiety Relief Supplements Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Anxiety Relief Supplements Revenue by Region
  1. 7.1 Global Anxiety Relief Supplements Revenue by Region
  2. 7.1.1 Global Anxiety Relief Supplements Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Anxiety Relief Supplements Revenue by Region (2021-2026)
  4. 7.1.3 Global Anxiety Relief Supplements Revenue by Region (2027-2032)
  5. 7.1.4 Global Anxiety Relief Supplements Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Anxiety Relief Supplements Revenue (2021-2032)
  8. 7.2.2 North America Anxiety Relief Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Anxiety Relief Supplements Revenue (2021-2032)
  11. 7.3.2 Europe Anxiety Relief Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Anxiety Relief Supplements Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Anxiety Relief Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Anxiety Relief Supplements Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Anxiety Relief Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 LONZA
  2. 8.1.1 LONZA Company Information
  3. 8.1.2 LONZA Business Overview
  4. 8.1.3 LONZA Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 LONZA Anxiety Relief Supplements Product Portfolio
  6. 8.1.5 LONZA Recent Developments
  7. 8.2 Takeda Pharmaceutical Co. Ltd.
  8. 8.2.1 Takeda Pharmaceutical Co. Ltd. Company Information
  9. 8.2.2 Takeda Pharmaceutical Co. Ltd. Business Overview
  10. 8.2.3 Takeda Pharmaceutical Co. Ltd. Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Pharmaceutical Co. Ltd. Anxiety Relief Supplements Product Portfolio
  12. 8.2.5 Takeda Pharmaceutical Co. Ltd. Recent Developments
  13. 8.3 Teva Pharmaceutical Industries Ltd.
  14. 8.3.1 Teva Pharmaceutical Industries Ltd. Company Information
  15. 8.3.2 Teva Pharmaceutical Industries Ltd. Business Overview
  16. 8.3.3 Teva Pharmaceutical Industries Ltd. Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Teva Pharmaceutical Industries Ltd. Anxiety Relief Supplements Product Portfolio
  18. 8.3.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  19. 8.4 Nestle S.A.
  20. 8.4.1 Nestle S.A. Company Information
  21. 8.4.2 Nestle S.A. Business Overview
  22. 8.4.3 Nestle S.A. Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nestle S.A. Anxiety Relief Supplements Product Portfolio
  24. 8.4.5 Nestle S.A. Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Anxiety Relief Supplements Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 The Nature's Bounty Co.
  32. 8.6.1 The Nature's Bounty Co. Company Information
  33. 8.6.2 The Nature's Bounty Co. Business Overview
  34. 8.6.3 The Nature's Bounty Co. Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 The Nature's Bounty Co. Anxiety Relief Supplements Product Portfolio
  36. 8.6.5 The Nature's Bounty Co. Recent Developments
  37. 8.7 Now Food
  38. 8.7.1 Now Food Company Information
  39. 8.7.2 Now Food Business Overview
  40. 8.7.3 Now Food Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Now Food Anxiety Relief Supplements Product Portfolio
  42. 8.7.5 Now Food Recent Developments
  43. 8.8 Nature's Sunshine
  44. 8.8.1 Nature's Sunshine Company Information
  45. 8.8.2 Nature's Sunshine Business Overview
  46. 8.8.3 Nature's Sunshine Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nature's Sunshine Anxiety Relief Supplements Product Portfolio
  48. 8.8.5 Nature's Sunshine Recent Developments
  49. 8.9 Herbalife
  50. 8.9.1 Herbalife Company Information
  51. 8.9.2 Herbalife Business Overview
  52. 8.9.3 Herbalife Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Herbalife Anxiety Relief Supplements Product Portfolio
  54. 8.9.5 Herbalife Recent Developments
  55. 8.10 GNC
  56. 8.10.1 GNC Company Information
  57. 8.10.2 GNC Business Overview
  58. 8.10.3 GNC Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GNC Anxiety Relief Supplements Product Portfolio
  60. 8.10.5 GNC Recent Developments
  61. 8.11 DuPont
  62. 8.11.1 DuPont Company Information
  63. 8.11.2 DuPont Business Overview
  64. 8.11.3 DuPont Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 DuPont Anxiety Relief Supplements Product Portfolio
  66. 8.11.5 DuPont Recent Developments
  67. 8.12 DSM
  68. 8.12.1 DSM Company Information
  69. 8.12.2 DSM Business Overview
  70. 8.12.3 DSM Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 DSM Anxiety Relief Supplements Product Portfolio
  72. 8.12.5 DSM Recent Developments
  73. 8.13 Ayanda
  74. 8.13.1 Ayanda Company Information
  75. 8.13.2 Ayanda Business Overview
  76. 8.13.3 Ayanda Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Ayanda Anxiety Relief Supplements Product Portfolio
  78. 8.13.5 Ayanda Recent Developments
  79. 8.14 Arkopharma
  80. 8.14.1 Arkopharma Company Information
  81. 8.14.2 Arkopharma Business Overview
  82. 8.14.3 Arkopharma Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Arkopharma Anxiety Relief Supplements Product Portfolio
  84. 8.14.5 Arkopharma Recent Developments
  85. 8.15 Amway Corporation
  86. 8.15.1 Amway Corporation Company Information
  87. 8.15.2 Amway Corporation Business Overview
  88. 8.15.3 Amway Corporation Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Amway Corporation Anxiety Relief Supplements Product Portfolio
  90. 8.15.5 Amway Corporation Recent Developments
  91. 8.16 Abbott Laboratories
  92. 8.16.1 Abbott Laboratories Company Information
  93. 8.16.2 Abbott Laboratories Business Overview
  94. 8.16.3 Abbott Laboratories Anxiety Relief Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Abbott Laboratories Anxiety Relief Supplements Product Portfolio
  96. 8.16.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anxiety Relief Supplements Value Chain Analysis
  2. 9.1.1 Anxiety Relief Supplements Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anxiety Relief Supplements Production Mode & Process
  6. 9.2 Anxiety Relief Supplements Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anxiety Relief Supplements Distributors
  9. 9.2.3 Anxiety Relief Supplements Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research